$12.31
0.04% today
Nasdaq, Nov 26, 04:47 pm CET
ISIN
US05368M1062
Symbol
CDMO

Avid Bioservices, Inc. Target price 2024 - Analyst rating & recommendation

Avid Bioservices, Inc. Classifications & Recommendation:

Buy
40%
Hold
60%

Avid Bioservices, Inc. Price Target

Target Price $12.75
Price $12.30
Potential
Number of Estimates 4
4 Analysts have issued a price target Avid Bioservices, Inc. 2025 . The average Avid Bioservices, Inc. target price is $12.75. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 5 analysts: 2 Analysts recommend Avid Bioservices, Inc. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Avid Bioservices, Inc. stock has an average upside potential 2025 of . Most analysts recommend the Avid Bioservices, Inc. stock at Hold.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Apr '24 2025
Estimates
Revenue Million $ 139.91 163.69
6.27% 17.00%
EBITDA Margin -5.41% 9.43%
174.03% 274.29%
Net Margin -101.67% -11.50%
88.69%

5 Analysts have issued a sales forecast Avid Bioservices, Inc. 2025 . The average Avid Bioservices, Inc. sales estimate is

$164m
Unlock
. This is
14.98% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$164m 15.34%
Unlock
, the lowest is
$163m 14.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $140m 6.27%
2025
$164m 17.00%
Unlock
2026
$198m 21.13%
Unlock
2027
$228m 15.02%
Unlock
2028
$283m 23.92%
Unlock
2029
$339m 20.00%
Unlock

5 Analysts have issued an Avid Bioservices, Inc. EBITDA forecast 2025. The average Avid Bioservices, Inc. EBITDA estimate is

$15.4m
Unlock
. This is
306.66% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$17.9m 339.63%
Unlock
, the lowest is
$14.2m 289.65%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-7.6m 169.39%
2025
$15.4m 303.93%
Unlock
2026
$32.3m 109.01%
Unlock
2027
$50.3m 55.75%
Unlock
2028
$77.7m 54.66%
Unlock
2029
$108m 39.34%
Unlock

EBITDA Margin

2024 -5.41% 174.03%
2025
9.43% 274.29%
Unlock
2026
16.27% 72.53%
Unlock
2027
22.04% 35.46%
Unlock
2028
27.50% 24.77%
Unlock
2029
31.94% 16.15%
Unlock

4 Avid Bioservices, Inc. Analysts have issued a net profit forecast 2025. The average Avid Bioservices, Inc. net profit estimate is

$-18.8m
Unlock
. This is
87.00% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-16.0m 88.99%
Unlock
, the lowest is
$-22.3m 84.58%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-142m
2025
$-18.8m 86.77%
Unlock
2026
$-4.5m 76.25%
Unlock
2027
$8.9m 299.78%
Unlock

Net Margin

2024 -101.67%
2025
-11.50% 88.69%
Unlock
2026
-2.25% 80.43%
Unlock
2027
3.92% 274.22%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Apr '24 2025
Estimates
Earnings Per Share $ -2.23 -0.30
86.55%
P/E negative
EV/Sales 5.85

4 Analysts have issued a Avid Bioservices, Inc. forecast for earnings per share. The average Avid Bioservices, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-0.30
Unlock
. This is
86.78% higher
Unlock
than earnings per share in the financial year 2024. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-0.25 88.99%
Unlock
, the lowest is
$-0.35 84.58%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-2.23
2025
$-0.30 86.55%
Unlock
2026
$-0.07 76.67%
Unlock
2027
$0.14 300.00%
Unlock

P/E ratio

Current -5.42 95.10%
2025
-41.69 669.19%
Unlock
2026
-175.71 321.47%
Unlock
2027
87.86 150.00%
Unlock

Based on analysts' sales estimates for 2025, the Avid Bioservices, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.72 97.65%
2025
5.85 12.97%
Unlock
2026
4.83 17.44%
Unlock
2027
4.20 13.06%
Unlock
2028
3.39 19.31%
Unlock
2029
2.82 16.66%
Unlock

P/S ratio

Current 5.53 139.70%
2025
4.81 13.03%
Unlock
2026
3.97 17.44%
Unlock
2027
3.45 13.06%
Unlock
2028
2.78 19.31%
Unlock
2029
2.32 16.67%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today